Azelastine Hydrochloride
NDC 47335-938, Azelastine Hydrochloride, solution/ drops, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 47335-938
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- SOLUTION/ DROPS
- Route
- INTRAOCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078738
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47335-938 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZELASTINE HYDROCHLORIDE.5 mg/mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47335-938-90 | 47335093890 | 1 BOTTLE, PLASTIC in 1 BOX (47335-938-90) / 6 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/04e5eede-17ff-4765-af77-d46c139da703
Use it
Look up 47335-938 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47335-938 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47335-938. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.